• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2021, Vol. 23 ›› Issue (4): 473-478.DOI: 10.3969/j.issn.1671-2587.2021.04.014

• 临床研究 • 上一篇    下一篇

三例伴有t(18;22)(q21;q11)慢性淋巴细胞白血病的细胞及分子遗传学研究*

向鑫, 刘恒芳, 曾招, 白淑潇, 岑建农, 金松, 沈宏杰, 陈苏宁, 潘金兰   

  1. 215006 苏州大学附属第一医院
  • 收稿日期:2021-04-01 出版日期:2021-08-20 发布日期:2021-08-18
  • 通讯作者: 潘金兰,女,主任技师,博士,主要从事血液病学研究,(E-mail)jinlanpan@126.com。
  • 作者简介:向鑫(1995-),女,湖南双峰县人,硕士,主要从事血液病学研究,(E-mail)xin991022@163.com。
  • 基金资助:
    *本课题受国家自然科学基金项目(No. 81600116)资助

Cytogenetic and Molecular Genetic Studies on Chronic Lymphocytic Leukemia with t(18;22)(q21;q11): Three Cases

XIANG Xin, LIU Heng-fang, ZENG Zhao, et al   

  1. Jiangsu Institute of Hematology,Suzhou 215006
  • Received:2021-04-01 Online:2021-08-20 Published:2021-08-18

摘要: 目的 分析伴有t(18;22)(q21;q11)慢性淋巴细胞白血病(chronic lymphocytic leukemia,CLL)的临床及实验室特征。方法 应用DSP30+IL-2刺激剂对慢淋细胞进行72 h刺激培养,采用常规方法制备染色体并利用R显带技术进行核型分析,进一步通过荧光原位杂交技术(fluorescence in situ hybridization,FISH)验证3例患者BCL-2基因重排,同时对例1患者进行全基因组测序分析,随访患者化疗疗效及生存情况。结果 3例患者均伴有t(18;22)(q21;q11)异常核型,FISH检测均为BCL-2重排,全基因组测序证实例1患者涉及BCL-2与IGL易位。结论 t(18;22)具有与t(14;18)不同的分子结构,且该异常核型发生率低,多见于CLL;伴有该异常核型的CLL可能具有难治性和易复发等特点。

关键词: t(18;22), (q21;q11), 慢性淋巴细胞白血病, BCL-2, 免疫球蛋白轻链

Abstract: Objective To analyze clinical characteristics and laboratory features of chronic lymphocytic leukemia (CLL) with t(18;22)(q21;q11). Methods CLL cells with DSP30+IL2 stimulant were cultured for 72 hours. Chromosome preparation and karyotype analysis were performed by routine method and R-banding technique. Furthermore, BCL-2 rearrangement in 3 cases was confirmed by fluorescence in situ hybridization(FISH). Meanwhile,we presented a whole genome sequencing(WGS) of case No.1. Patients were followed-up for chemotherapy efficacy and survival. Results Abnormal karyotype described as t(18;22)(q21;q11) were showed in all 3 patients. FISH analysis revealed BCL2 rearrangement. WGS confirmed a BCL-2 and IGL translocations in case No.1. Conclusion t(18;22) has different molecular structure from t(14;18)and the incidence of abnormality is low. It is more common in CLL. CLL with this abnormality may be refractory and easy to relapse.

Key words: t(18;22), (q21;q11), CLL, BCL-2, IGL

中图分类号: